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Aims Inappropriate Sinus Tachycardia (IST), a syndrome characterized by abnormally fast sinus rates and multisystem symp-
toms, is still poorly understood. Because of the relevance of HCN4 channels to pacemaker activity, we used a candi-
date-gene approach and screened IST patients for the presence of disease-causing HCN4 mutations.
Methods
and results
Forty-eight IST patients, four of whom of known familial history, were enrolled in the study. We initially identified in one
of the patients with familial history the R524Q mutation in HCN4. Investigation extended to the family members
showed that the mutation co-segregated with IST-related symptoms. The R524Q mutation is located in the C-linker,
a region known to couple cAMP binding to channel activation. The functional relevance of the mutation was investi-
gated in heterologous expression systems by patch-clamp experiments. We found that mutant HCN4 channels were
more sensitive to cAMP than wild-type channels, in agreement with increased sensitivity to basal and stimulated adren-
ergic input and with a faster than normal pacemaker rate. The properties of variant channels indicate therefore that
R524Q is a gain-of-function mutation. Increased channel contribution to activity was confirmed by evidence that
when spontaneously beating rat newborn myocytes were transfected with R524Q mutant HCN4 channels, they ex-
hibited a faster rate than when transfected with wild-type HCN4 channels.
Conclusion This is the first report of a gain-of-function HCN4 mutation associated with IST through increased sensitivity to cAMP-
dependent activation.
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Translational perspective
Inappropriate Sinus Tachycardia (IST) is a type of sinus node dysfunction that can be inherited and has therefore a genetic background.
Based on the established role of pacemaker HCN4 channels in controlling heart rhythm, we explored the possibility that mutations of
HCN4 are associated with IST. Our study shows for the first time that an inheritable form of IST, identified in an Italian family, is linked
to a novel gain-of-function HCN4 mutation. Our finding provides a molecular basis to explain why one of the mechanisms thought to
lead to IST involves excessive sensitivity to sympathetic stimuli.
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Introduction
Inappropriate Sinus Tachycardia (IST) is associated with fast resting
sinus rates and exaggerated heart rate (HR) responses that are
unrelated to physiological need. Clinical symptoms are variable
and range from symptomatic palpitations and activity intolerance
to multisystem complaints including recurrent syncope, light-
headedness, orthostatic intolerance and others.1 – 4 Its reported
frequency in the middle-aged population is 1.16%.1 Although its
aetiology is still largely unknown, several mechanisms including
excessive sympathetic or reduced parasympathetic drive, excessive
intrinsic HR, dysfunctional neurohormonal modulation, ectopic
activity of the SAN, and b-adrenergic-receptor autoantibodies are
suggested substrates for IST.2 – 5 Channellopathies have also been
suggested as potential underlying mechanisms.6
Hyperpolarization-activated Cyclic Nucleotide-gated (HCN4)
proteins, the constitutive elements of the pacemaker ‘funny’
(f)-channels, provide a large fraction of the inward current under-
lying the diastolic depolarization, and have a major role in cardiac
rhythm generation and autonomic modulation of HR.7 –9 The basic
biophysical properties and the physiological role of pacemaker
channels have long been investigated, but there is now growing
interest for clinically relevant applications of the concept of
f channel-based pacemaking.10,11 One important clinical conse-
quence of this concept is the finding that dysfunctional HCN4
mutations are associated with familial types of arrhythmias.12– 15
Several HCN4 mutations have been proposed to be arrhythmo-
genic. Functional studies show that all mutations investigated so far
are loss-of-function, and in agreement with the established role of
the channels in pacemaking, most of these mutations are indeed
associated with bradycardia, although more complex arrhythmias
such as AF, tachy-brady syndrome, atrioventricular (AV) block, as
well as structural diseases such as noncompaction cardiomyopathy
and prolapse of the mitral valve, have also been reported.12–14 Des-
pite intense investigation, no gain-of-function mutations, which
might be expected to cause cardiac acceleration, have been de-
scribed so far. We have screened patients with tachyarrhyhmias in
the attempt to search for causative HCN4 mutations. Here we re-
port the case of a gain-of-function mutation in the hHcn4 gene found
in four adults and one child of an Italian family which co-segregates
with symptoms of sinus tachyarrhtymia.
Functional investigation shows that R524Q mutant channels
have a higher than normal cAMP sensitivity and carry a larger than
normal current during the diastolic depolarization, providing the
first evidence for a gain-of-function pacemaker channel mutation
associated with tachyarrhythmias.
Methods
Here we outline the major study protocols adopted. An extended
methods section is available in Supplementary material online.
Including criteria
Entry criteria were as described previously2 and included: symptomatic
mean resting HR ≥ 95 bpm during the daytime hours of 24-h Holter
monitoring and/or a rapid stable symptomatic increase in resting
HR . 25 bpm when moving from a supine to a standing position or in
response to biological stress.
Genomic DNA analysis and mutagenesis
Written informed consent was obtained from each subject prior to car-
rying out genetic analysis. The coding sequence of the hHCN4 gene was
amplified by PCR starting from genomic DNA extracted from whole
blood or saliva (Puragene Blood Kit, Qiagen). The primers were de-
signed to amplify DNA fragments of 149 to 395 bp (Supplementary ma-
terial online, Table S1) in order to screen all the coding portion of the
hHcn4 gene. The PCR reaction mixture included 100 ng of genomic
DNA, 1 mM primers and the FastStart Taq DNA Polymerase (Roche
Diagnostics). The PCR cycling reaction consisted of initial denaturation
for 5 min at 958C, and 30 cycles with denaturation of 30 s at 958C, an-
nealing for 30 s at different temperature and extension for 30 s at 728C.
The primers 5′TTCCCTCTCATCCACTGTCCC3′ (F) and 5′GACC
AATGTGCGGGTGCTCC3′ (R) were used to amplify exon 4, where
the pathological mutation 1571g  a (R524Q) is located. Analysis of
the amplicons was carried out by single-strand conformation poly-
morphism. The presence of mutations was confirmed by DNA
sequencing (Bio-Fab Research).
For functional studies, both in HEK293 cells and neonatal rat myocyte
cultures we used hHCN4 cDNA cloned into the pcDNA 1.1 vector.
The mutation of interest was incorporated into the hHCN4 cDNA
sequence by means of a commercial kit (QuikChangew Site-Directed
Mutagenesis, Agilent Technologies). The primers used were: 5′CTGG
ACTCCTCCCAGCGCCAGTACCAG3′ (F) and 5′CTGGTACTGG
CGCTGGGAGGAGTCCAG3′ (R).
Statistical analysis
Activation and dose–response curves were compared using the Extra
sum of squares F test followed by one-way ANOVA and post hoc tests.
Group comparisons were made with unpaired Student’s t-test or one-
way ANOVA followed by post hoc tests. P-values of 0.05 or less were
considered to indicate statistical significance. Statistical analysis were
carried out with OriginPro 9.1, OriginLab Corporation, USA and
GraphPad Prism 5, GraphPad Software, USA. Unless otherwise
indicated data are expressed as mean+ SEM.
Results
R524Q mutation in a family with
Inappropriate Sinus Tachycardia
Forty-eight patients affected by IST (four of whom with familial
history of IST) were tested for the presence of mutations in the
coding region of the cardiac pacemaker channel gene Hcn4. The
screening led to the identification in an adult female (proband) of
the mutation 1571g a, which generates the missense aminoacidic
substitution R524Q in exon 4 of one allele (Supplementary material
online, Figure S1). Genetic analysis was then extended to eight other
members of the family and the mutation was identified in three
more adults and in one child (Figure 1A).
The mutation 1571g a (R524Q) was not identified in a group of
200 healthy subjects and we therefore excluded the possibility of a
DNA polymorphism. One case is reported for a single allele over
1092 individuals from 14 populations in the 1000 Genomes
Project.16 Analysis with the SIFT algorithm17 identified this mutation
as deleterious, with a normalized probability to be tolerated of 0.0002.
Arginine 524 is conserved among all human HCN isoforms and
throughout the animal kingdom from insects to man, but not in
the echinoderm Strongylocentrotus purpuratus and the cnidarian
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Nematostella vectensis, while a synonymous mutation (to lysine) is
found in the urochordate Ciona intestinalis (Figure 1E).
The clinical profile of the proband (II-4 in Figure 1A) was character-
ized by prolonged periods of symptomatic sinus tachycardia
(Figure 1B), frequent palpitations at rest and/or during effort and
anxiety, orthostatic intolerance with syncope (Supplementary
material online, Figure S2), reproducible dyspnoea on effort
limiting or causing early termination of any physical activity, and light-
headedness. At electrocardiogram (ECG) Holter-monitoring,
daytime HR (8 am to 9 pm) had a mean+ SD value of 98.5+
14.2 bpm (Figure 1C and D). The patient was diagnosed as IST after
excluding other mechanisms potentially causing compensatory tachy-
cardia such as: structural heart disease, neuroendocrine disorder,
postural hypotension, fever, anaemia, pregnancy, and medications.
Among the other family members also carrying the mutation, all
adults (I-2, II-1, II-3, Figure 1A) were affected by palpitations at
baseline and anxiety, while the young girl (III-1) was asymptomatic.
In individuals II-1, II-3, II-4, and III-1, episodes of symptomatic or
asymptomatic unjustified sinus rhythm acceleration and deceler-
ation were repeatedly recorded. In individual I-2 (proband’s
mother) multiple ECG recordings carried out in a 5-year period
confirmed the presence of sinus tachycardia with resting HRs in
the range of 100 bpm (103.3 bpm in the ECG of Figure 2A; see Sup-
plementary material online, Table S2). The proband’s sister (II-1)
also presented with orthostatic intolerance and light-headedness;
Holter monitoring revealed multiple phases of sudden unexplained
sinus tachycardia unrelated to physical activity during both day and
night (Figure 2B).
Figure 1 HCN4 mutation associated with Inappropriate Sinus Tachycardia. (A) Pedigree of a three-generation family with Inappropriate Sinus
Tachycardia (the arrow indicates the proband). Individuals with Inappropriate Sinus Tachycardia symptoms and/or unjustified sinus tachycardia are
labelled by red symbols; dots indicate members of the family carrying the heterozygous mutation R524Q, empty symbols are wild-type, grey sym-
bol indicates a genetically unrelated individual. The twins II-2 and II-3 are heterozygous. (B) Twelve-lead ECG recorded at baseline in the proband;
the heart rate is 103 bpm and the P wave is indicative of sinus node origin. (C) Plot of daytime heart rate (from 8 am to 9 pm) recorded in the
proband during Holter monitoring; the mean rate was 98.5+14.2 bpm (mean+ SD). (D) Histogram of daytime R–R intervals recorded during
Holter monitoring. (E) Sequence alignment of the C-linker region of human HCN isoforms and of corresponding regions of homologous channel
proteins from different species. Red bars above the sequences indicate a-helices. Significance of symbols is as follows: Rat, Rattus norvegicus; AC,
Anolis carolinensis; MG, Meleagris gallopavo; LC, Latimeria chalumnae; PA, Panulirus argus; DM, Drosophila melanogaster; Ciona, Ciona intestinalis; SP,
Strongylocentrotus purpuratus; NV, Nematostella vectensis. Arginine 524 of hHCN4 (arrow) is in the region most proximal to the S6 domain.
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Individual II-3 is an adult male with a history of recurrent syncope
associated with binodal dysfunction characterized by sinus brady-
cardia and phases of first and second degree LW AV block asso-
ciated with enhanced vagal tone (Figure 3A and C and
Supplementary material online, Table S2). Despite the prevalent
bradycardia, this individual presented several unexpected bursts of
increasing HR at rest. Phases of sinus tachycardia typically mani-
fested with ‘warm-up’ characteristics and were abruptly interrupted
by phases of bradycardia (Figure 3B and C ), likely induced by a robust
vagal discharge.18 Although these events were particularly frequent
at nighttime (Figure 3C), they were also observed during the day
(Figure 3B) where they were associated with transient symptomatic
sinus tachycardia.
Individual III-1 (proband’s daughter) is a healthy young girl
who did not report specific cardiac symptoms. Nonetheless,
Holter monitoring revealed phases of anomalous tachycardia
(Supplementary material online, Figure S3) unrelated to any physical
activity or emotional stress.
No signs of IST or other cardiac arrhythmic abnormalities were
found in the adult (I-1, II-2) or young (III-2, III-3) family members
carrying the HCN4 wild-type genetic profile.
A summary of clinical profiles of all members of the family is given
in Supplementary material online, Table S2.
Functional analysis by heterologous
expression in HEK293 cells
The R524 residues of human HCN4 channels are located in the initial
part of the C-linker (Figures 1E and 4), a region connecting the S6
transmembrane domain to the cyclic nucleotide binding domain
(CNBD) which functionally couples the binding of the second
messenger cAMP to channel activation; in the tetrameric channel
assembly they form a ring of positively charged amino acids which
surrounds the internal mouth of the channel (Figure 4B). As shown
in Figures 1 and 4B, the residue R524 is located in the first portion
of the A′ a-helix of the C-linker, in close proximity to the S6 domain.
Figure 2 Episodes of unjustified sinus tachycardia recorded at rest from the proband’s mother (I-2) and sister (II-1). (A) Twelve-lead electro-
cardiogram recordings at rest from the proband’s mother; the mean heart rate was 103.3 bpm. (B) Stretches of Holter recording showing the
occurrence in the proband’s sister (II-1) of episodes of sinus tachycardia at rest during daytime (left, 111.5 bpm) and night (middle, 94.3 bpm).
P wave morphology was the same as that recorded during normal sinus rhythm (right, 56.6 bpm).
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We investigated the kinetic properties of channels by patch-
clamp analysis of HEK293 cells transfected with wild-type (wt)
and mutated hHCN4 cDNA. Both channel types were expressed
with similar efficiency; mean current densities measured at
2145 mV were: 250.7+ 11.5 (n ¼ 16), 256.5+ 11.7 (n ¼ 14),
and 248.2+ 6.9 pA/pF (n ¼ 21) for wt, heteromeric wt-R524Q
and homomeric mutant R524Q channels, respectively (not signifi-
cantly different, P. 0.05).
However, the mutation increased availability of the pacemaker
current by shifting to more depolarized voltages the activation curve
of whole-cell currents by 4.2 mV in heteromeric wt-R524Q
channels and 7.6 mV in homomeric mutant R524Q channels
(Figure 5A, top).
We reasoned that differences in the half-activation (V1/2) values of
activation curves could reflect intrinsic new properties of mutant
channels or differences in the sensitivity to basal cytoplasmic
cAMP. To verify this, we exposed cells to a saturating cAMP concen-
tration (10 mM) in the whole-cell pipette solution. Under these
conditions, all activation curves overlapped and their V1/2 values
did not differ significantly (Figure 5A, bottom); thus, while the
cAMP-induced shift of V1/2 in wt channels (13.0 mV) had the
expected size,19,20 it was significantly reduced in wt-R524Q
(8.3 mV) and R524Q channels (4.6 mV) (P, 0.05; Figure 5B).
These data suggest an increased cAMP sensitivity of mutant
channels, the shifts observed in whole-cell conditions in Figure 5A
reflecting higher response to basal cytoplasmic cAMP of mutant
vs. wt channels. To confirm this hypothesis, we investigated the
action of cAMP in inside-out macro patches. As shown in
Figure 5C, mean activation curves of wt, wt-R524Q, and R524Q
channels measured with a voltage ramp protocol in a cAMP-free
intracellular solution overlapped, indicating that the mutation did
not modify the intrinsic voltage dependence of channels in the
absence of cAMP. A cAMP concentration of 0.1 mM, on the other
hand, was more effective on mutant than on wt channels
(Figure 5D, top). Measuring for a fuller assessment of the cAMP
dependence the dose–response relationships of the V1/2 shift
against cAMP concentration for the three channel types
(Figure 5D, bottom) showed that indeed mutant channels have a
higher cAMP sensitivity.
We additionally verified that ivabradine 3 mM blocks wt and
R524Q channels in a similar way (wt: 68.0+ 4.1%, n ¼ 6; R524Q:
64.0+ 8.1, n ¼ 6; P. 0.05).
R524Q mutant proteins increase
automaticity in neonatal cardiac myocytes
The data in Figure 5 show that R524Q channels respond more
strongly to cAMP and provide a basis to predict an abnormally
fast, b-adrenergic sensitive cardiac rhythm of patients carrying the
mutation. For a direct evaluation of the effects of the mutation on
beating rate, we transfected wt and/or mutant channels into rat
neonatal cardiac myocytes21 (Figure 6). Cardiomyocytes were
co-electroporated with wt and/or mutant channel cDNA and
with GFPmax-containing plasmids to allow for the identification of
green cells. HCN4 channel expression was equally robust in all
groups and mean current densities measured at 2125 mV values
were not significantly different: 239.4+ 8.2 (n ¼ 6), 234.6+6.6
(n ¼ 6), and 237.6+ 6.1 (n ¼ 7) pA/pF for wt, wt-R524Q, and
R524Q channels, respectively (P . 0.05); for comparison, cells
expressing the GFPmax reporter only had a current density of
Figure 3 ECG-Holter recordings from the proband’s brother
(II-3). (A) Plot of heart rate (from 8 pm to 9 am) during Holter
monitoring. Sinus rhythm was prevalently bradycardic with several
episodes of 2:1 AV block particularly during sleep. Arrows indicate
correspondence with enlargements in (B) and (C). (B) Time course
of heart rate (bottom) and corresponding electrocardiogram re-
cording (top) associated with symptomatic palpitation and anxiety
at rest during the day, as reported by the patient. (C) Time course
of heart rate (bottom) and corresponding electrocardiogram re-
cordings (top) showing an episode of asymptomatic sinus tachy-
cardia recorded at night during sleeping (top, right). Sinus node
tachycardia occurs on a baseline condition of sinus bradycardia
during which several episodes of I and II degree AV block were pre-
sent (top, left). Atrioventricular blocks are associated with en-
hanced vagal tone, as shown by the increase in PP interval
duration in correspondence with the AV block. PP intervals prior
to, during, and after block were (ms): 1060, 1040, 1040, 1160, 1140
(block), 1128, and 1012. P wave morphology was unchanged dur-
ing the whole recording. ‘Warm-up’ events characterized by in-
appropriate sinus tachycardia followed by sudden rate slowing
are apparent in both panels. See Supplementary material online,
Table S2 for further clinical information.
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23.6+ 0.8 pA/pF (n ¼ 9; t-test with Welch correction, P, 0.05 vs.
control). Transfected cells acquired a constant, regular rate as pre-
viously shown.21
We compared the activity of cells expressing wt and mutant
channels, and found that the latter beat faster (Figure 6B and D).
Relative to wt (65.6+ 3.7 bpm, n ¼ 9), the mean spontaneous
rate was 34.7% (88.4+ 9.0 bpm, n ¼ 9) and 72.2% faster
(113.0+ 5.8 bpm, n ¼ 10) in cells expressing wt-R524Q and
R524Q channels, respectively (P, 0.05; Figure 6D). Video detec-
tion measurements of rate contraction were also performed,
and mean rates of 65.2+ 5.4 bpm (n ¼ 10) and 96.6+ 9.3 bpm
(n ¼ 10, 48.2% acceleration) were measured from wt and
R524Q-channel expressing cells, respectively (Supplementary
material online, Video S1).
A faster spontaneous rate is expected in the presence of a larger
pacemaker current. We thus checked if in cardiomyocytes, as in
HEK293 cells, the current availability was increased by the mutation
and indeed found that the fractional current activation increased in
mutant channels in the mid-activation range (see 275 mV records
in Figure 6A) and that mean activation curves were shifted to more
positive voltages by 3.9 and 7.3 mV in wt-R524Q and R524Q
channels, respectively (Figure 6C).
Discussion
We report here the first evidence for a heterozygous gain-of-function
mutation in the pacemaker HCN4 channel associated with symptoms
of IST.
All arrhythmogenic mutations in HCN4 reported so far are
loss-of-function and, accordingly, are mostly associated with
bradycardia.12–14
In this work, all family members carrying the mutation R524Q
displayed unjustified phases of symptomatic or asymptomatic tachy-
cardia, both at rest and during sleep, as assessed by objective evalua-
tions (ECG and Holter monitoring) and by subjectively reported
symptomatology. Different clinical profiles likely reflect the pres-
ence of incomplete penetrance and variable expressivity as it occurs
in almost all channelopathies.22 – 24 Phenotypical heterogeneity
could derive, for example, from individual variability in the auto-
nomic control of HR. A similar mechanism, proposed to explain
differential arrhythmic risk in LQT1 patients, has been recently iden-
tified, for example, in KCNQ1 A341V mutation carriers.23 Similarly,
studies carried out by Berge et al.25 and by Priori et al.26 estimated
penetrance values of 41 and 16%, respectively, in LQTS-associated
and in BrS-associated genes.
Figure 4 Spatial localization of the R524Q mutation. (A) Schematic representation of the topology of one HCN4 channel subunit. The six trans-
membrane domains (S1–S6) and the intracellular N- and C-termini are shown. The C-linker includes six a-helices (A′ to F′) as according to
Figure 1E, and the cyclic nucleotide-binding domain includes 4 a-helices (A, P, B, and C) as indicated. The red dot indicates the approximate pos-
ition of the mutation R524Q. (B) 3D model reconstruction of the human HCN4 channel C-terminal domain viewed from the membrane (left) and
from the side (right). All four subunits are shown as cartoon plots, two in dark and two in light orange. R524 residues in the C-linkers, mutated to
Q, are drawn as spheres. C-linker a helices of one subunit are labelled in the left panel. The reconstruction is based on a previously published
crystal structure of the HCN4 C-terminus41 (PDB code 3OTF).
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Inappropriate Sinus Tachycardia has recently received much
medical attention since several laboratories have reported that pa-
tients resistant to treatment with conventional rate-decreasing
medications can be successfully treated with ivabradine, a specific
inhibitor of the If current.2,27 – 30 The evidence that the If current
is an effective pharmacological target in IST treatment highlights
on the one hand its role as a major mechanism for HR control,
and supports on the other its potential involvement in IST aetiology.
Residue R524 is located in the first a-helix (A′) of the C-linker, a
stretch of 81 residues connecting the cytoplasmic end of the S6
segment to the CNBD. Previous crystallographic and functional
studies of mHCN2 channels have shown that C-linkers contribute
essentially to the structural re-arrangements involved in the
cAMP-induced modulation of the channel.31–33
We found that substitution of the positively charged arginine with
the polar, uncharged glutamine does not modify the intrinsic voltage
dependence of channel activation (Figure 5C), but does increase its
sensitivity to cAMP (Figure 5A–D). From the dose–response curves
in Figure 5D the half-maximal cAMP concentration was decreased
4.6-fold (from 1.67 to 0.35 mM) in heterozygous wt-R524Q,
and .20-fold (from 1.67 to 0.080 mM) in homozygous R524Q
mutant channels.
The mutation R524Q involves the change of electrical charge
distribution in the C-linker. Although our study did not address
the structural basis of the effects of the R524Q mutation, it is worth
noting that several previously reported arrhythmogenic missense,
loss-of-function hHCN4 mutations of C-terminus residues (such
as K530N, D553N, S672R, and P883R) involve a change of electric
Figure 5 Wild-type and mutated channel expression in HEK293 cells. (A) Mean activation curves of HCN4 current measured in HEK293 cells in
control (upper) and in the presence of 10 mM cAMP in the whole-cell pipette (lower). Datapoints are means from n ¼ 6–10 cells. The values of
V1/2 from Boltzmann fitting (full lines) are: 277.8, 273.6, and 270.2 mV (top) and 264.8, 265.3, and 265.6 mV (bottom) for wild-type (open
circles), heteromeric wt-R524Q mutant (grey squares) and homomeric R524Q mutant channels (filled circles), respectively. All curves were sig-
nificantly different in control, but not in the presence of cAMP. Curves in the upper panel are replotted as broken lines in the lower panel. (B) Mean
V1/2 calculated from Boltzmann fitting of single-cell activation curves (n ¼ 6–10 cells). Values in the presence of cAMP are boxed. (C ) Mean ac-
tivation curves of wt, wt-R524Q, and R524Q channels averaged from 9, 7, and 9 curves, respectively, as measured in inside-out macropatches by
slow voltage ramps42 in the absence of cAMP. (D) Dose–response relationships of cAMP dependence of activation curve shift measured in inside-
out macropatches expressing wt, wt-R524Q, and R524Q channels. Each datapoint is the average of 3–10 exposures. Parameters of Hill fitting of
these curves are: Kd ¼ 1.67, 0.35, and 0.080 mM and h ¼ 0.55, 0.41, and 0.36 for wt, wt-R524Q, and R524Q channels, respectively. Maximal shift
was fixed to Smax ¼ 11.9 mV for all curves. Top panels: sample inside-out traces in control (c), during perfusion with cAMP (*) and upon return (r).
Horizontal bar: 1 s; vertical bar: 20 pA.
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charge,34 and that several findings indicate that channel gating is af-
fected by the electric charge distribution in the C-terminus.32,35–37
Also interestingly, cAMP is known to have an exaggerated activat-
ing action on the HCN-homologous channel of the sea urchin
(SPIH), where the residue homologous to arginine 524 is a serine
(SP in Figure 1E).35
In contrast with our data, the K530N mutation previously
reported by Duhme et al.38 is to be classified as loss-of-function
since it is associated with a strong negative shift of the activation
voltage dependence of the pacemaker current,13,14 which repre-
sents the rational mechanistic link to the manifestation of
Brady-arrhythmias reported in their work. Interestingly, the authors
report also a larger than normal response to cAMP of the hetero-
meric wt + mutant channel (though not of the homomeric mutant
channel); this lends further support to the view that the C-linker re-
gion comprising R524 and K530 residues is involved in mediating the
cAMP-induced modulation of the channel.
Whichever the mechanism involved, our data show that the
R524Q mutation causes a higher cAMP sensitivity, resulting in a
rightward shift of the activation curve (Figures 5 and 6), a property
that mimics the effect of b-adrenergic stimulation.39 Accordingly,
newborn myocytes pace faster when transfected with mutant rather
than wt channels (Figure 6).
Exaggerated b-receptor stimulation operated by autoantibodies
and the associated cAMP elevation are known causes of IST.5,40
Our data therefore provide an explanation for the link between
b-receptor stimulation by autoantibodies and IST.
Because of the properties of R524Q channels, our data support the
view that individuals carrying this mutation are in a permanent state of
higher than normal channel activation and/or associated rhythm
acceleration. Our results thus provide a basis to explain the faster in-
trinsic HR and the hypersensitivity to sympathetic stimulation typical
of IST.2,4 They also explain why ivabradine, a known ‘pacemaker’
channel blocker used in the therapy for angina and heart failure, is
today considered as an emerging new therapy for IST.2,4 R524Q is
the first example of a gain-of-function mutation in hHCN4 associated
with IST, and may represent a special case of a more general mechan-
ism of HCN4-linked cardiac tachyarrhythmias. Our results introduce
the concept that IST can have a genetic basis and raises the possibility
that inheritable IST traits are less infrequent than previously believed.
Figure 6 Wild-type and mutated channel expression in rat neonatal myocytes. (A) Sample current and (B) free-running voltage traces recorded
in cells expressing wt (left), wt-R524Q (middle), and R524Q channels (right). Currents in (A) were measured during two-step protocols to the
voltages indicated. In (A) and (B): horizontal bar: 2 and 1 s; vertical bar: 500 pA and 20 mV, respectively. (C ) Mean activation curves (each point is
the average of data from n ¼ 4–10 cells). The values of V1/2 from Boltzmann fitting were: 274.8, 270.9, and 267.5 mV for wt, wt-R524Q, and
R524Q curves, respectively. (D) Mean spontaneous rates were 65.6+3.7 (n ¼ 9), 88.4+9.0 (n ¼ 9), and 113.0+5.8 bpm (n ¼ 10) in cells ex-
pressing wt, wt-R524Q, and R524Q channels, respectively. All values are significantly different from each other (P, 0.05).
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